https://medicine.ouhsc.edu/academic-departments Parent Page: Academic Departments id: 22947 Active Page: Symposium 2025id:31296

8th Annual Oklahoma Urologic Symposium

  

Date & Location 

Friday, August 22nd, 2025, 6:30 AM - 4 PM, Samis Education Center, 1200 Children's Ave, Oklahoma City, OK

Learn More

 The Symposium will provide a comprehensive and up-to-date review of the most significant advances in urologic care, featuring distinguished faculty from the OU College of Medicine and invited experts. Topics will cover a range of clinical and emerging areas, including the management of recurrent prostate cancer after radiation therapy, new approaches in ablative therapy, and advancements in radiation therapy for localized prostate cancer. Attendees will also engage in a panel discussion on prostate cancer, as well as emerging intravesical therapies for NMIBC, invasive bladder cancer updates, and bladder cancer case reviews. Key presentations will focus on adjuvant therapy for high-risk renal cell carcinoma, the role of surgery in advanced renal cell carcinoma, and novel treatments such as Cretostimogene grenadenorepvec for high-risk BCGu NMIBC.

In the afternoon, the agenda shifts to important updates in clinical practice, including the 2024 AUA OAB guideline and the management of Peyronie’s disease. Perioperative considerations in urethral stricture will also be addressed, followed by a panel discussion on female pelvic cases. Additional topics will feature pediatric urology updates, and a unique session with resident case presentations.

Urologists, Primary Care Physicians, Specialty Physicians, Oncologists, Radiation Oncologists, Related Physician Assistants, Nurses, Nurse Practitioners, Navigators, and other Administrative Staff Supporting Oncology Programs.

 

 

  • Describe the role of emerging therapies and surgical approaches in the management of prostate cancer recurrence after radiation therapy.
  • Identify advancements in the treatment of non-muscle invasive bladder cancer (NMIBC) and their potential impact on clinical practice.
  • Apply recent updates in guidelines and treatment strategies for pelvic health, including OAB and Peyronie’s disease, to improve patient outcomes in clinical setting

  

Keynote Speakers

 

Mark D. Tyson, II, MD, MPH

Associate Professor of Urology & Vice chair for research, Department of Urology, Mayo Clinic Arizona

 

 

 

Michelle E. Van Kuiken, MD

Assistant Professor of Urology & Associate Program Director, UCSF Urology Graduate Medical Education

Registration

Accreditation

Joint Accreditation Statement

The University of Oklahoma Health Science

2025 Oklahoma Urologic Symposium
August 22, 2025
Oklahoma City, OK
 

 

CME Logo Image Small638164100560611227

 

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and The University of Oklahoma Health Science Center. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians (ACCME) Credit Designation

Amedco LLC designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits TM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioners

The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP.

Physician Assistants

PAs may claim a maximum of 6.75 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.